In Reply
- 20 January 2005
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (3) , 654-655
- https://doi.org/10.1200/jco.2005.05.260
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?Journal of Clinical Oncology, 2004
- Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon CancerNew England Journal of Medicine, 2003
- Clinical research by community oncologists.CA: A Cancer Journal for Clinicians, 2003
- Survival Associated with 5-Fluorouracil–Based Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon CancerAnnals of Internal Medicine, 2002
- A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly PatientsNew England Journal of Medicine, 2001
- Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to EnrollmentJournal of Clinical Oncology, 2001
- Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancerThe Lancet, 2000